COVID-19 is a highly infectious respiratory infection, first identified in late 2019. It can spread quickly and cause serious illness, hospitalisation and death; however, a significant proportion of infections are asymptomatic.
COVID-19 vaccines have been approved for use by the Medicines and Healthcare products Regulatory Agency (MHRA) and vaccinations started in the UK on 8 December 2020.
These web pages are intended for people who are part of the workforce involved in delivering the COVID-19 vaccination programme. The purpose of these web pages is to provide this workforce with a dedicated online space where accurate information and useful resources regarding COVID-19 vaccination in Scotland can be collated and easily accessed.
This information will be updated regularly and can help you stay informed about the COVID-19 vaccination programme.
FVCV Programme in Public Health Scotland
The Scottish Government Flu Vaccines and COVID-19 Vaccinations Delivery (FVCV) Programme was set up to ensure the readiness of Scotland for the implementation of an expansion to the flu vaccination programme and delivery of a COVID-19 vaccination, as per recommendations of the Joint Committee for Vaccinations and Immunisations (JCVI) and Scottish Government.
Public Health Scotland has a key role in contributing to monitoring and responding to COVID-19 vaccine safety, supporting the safe delivery of the COVID-19 Vaccination programme by working in partnership with our NHS Board colleagues and UK bodies such as the Medicines and Healthcare products Regulatory Agency (MHRA). A Clinical Governance Group was established in November 2020 and is co-chaired by Public Health Scotland and The Scottish Government to provide national-level clinical leadership for the FVCV Programme. This includes overseeing effective mechanisms to monitor, evaluate and assure the clinical aspects of the wider COVID-19 programme.
- CMO letter – JCVI advice on the vaccination of severely immunosuppressed individuals (external website)
- CMO letter – National policy on offering COVID-19 vaccinations to 12 to 15 year olds (external website)
- JCVI statement on COVID-19 vaccination of children and young people aged 12 to 15 years - 3 September (external website)
- CMO letter – JCVI advice for vaccination of 16 and 17 year olds (external website)
- Greenbook - Chapter 14a has been updated (16 September 2021)
- JCVI statement on COVID-19 vaccination of children and young people aged 12 to 17 years (external website)
- JCVI statement on use of the AstraZeneca vaccine (external website)
- CMO letter B.1.617.2 Variant (external website)
- Allergy Management and Patient Screening tools
- JCVI interim advice on COVID-19 booster vaccine programme winter 2021-2022 (external website)
- Vaccine self-registration portal for all ages is now live (external website)
- Review of extremely rare reports of myocarditis and pericarditis (external website)
- Guillain-Barré Syndrome information for healthcare professionals (external website)
- Myocarditis and pericarditis information for healthcare professionals (external website)